GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Weed Inc (OTCPK:BUDZ) » Definitions » Earnings Yield (Joel Greenblatt) %

Weed (BUDZ) Earnings Yield (Joel Greenblatt) % : 0.17% (As of Dec. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Weed Earnings Yield (Joel Greenblatt) %?

Weed's Enterprise Value for the quarter that ended in Dec. 2023 was $8.89 Mil. Weed's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $0.02 Mil. Weed's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2023 was 0.17%.

The historical rank and industry rank for Weed's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

BUDZ' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -24.57   Med: 0   Max: 0.19
Current: 0.16

During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Weed was 0.19%. The lowest was -24.57%. And the median was 0.00%.

BUDZ's Earnings Yield (Joel Greenblatt) % is ranked worse than
60.2% of 1093 companies
in the Drug Manufacturers industry
Industry Median: 2.49 vs BUDZ: 0.16

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Weed's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2023 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


Weed Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for Weed's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Weed Earnings Yield (Joel Greenblatt) % Chart

Weed Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings Yield (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -78.13 -15.90 -8.86 -12.90 0.17

Weed Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.90 -13.07 -12.39 -4.01 0.17

Competitive Comparison of Weed's Earnings Yield (Joel Greenblatt) %

For the Drug Manufacturers - Specialty & Generic subindustry, Weed's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Weed's Earnings Yield (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Weed's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Weed's Earnings Yield (Joel Greenblatt) % falls into.



Weed Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

Weeds Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2023 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=0.015/8.892259
=0.17 %

Weed's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02 Mil.



Weed  (OTCPK:BUDZ) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


Weed Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of Weed's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


Weed (BUDZ) Business Description

Industry
Traded in Other Exchanges
N/A
Address
4920 North Post Trail, Tucson, AZ, USA, 85750
Weed Inc is working on or planning for several different business opportunities in the cannabis and hemp field, including, but not limited to both indoor and outdoor grows, cultivations, and harvest for research, product development, processing, and manufacturing of both Pharma and non-Pharma products, services, therapeutics, and treatments on a global basis for both the Medical Cannabis and Hemp global market space.
Executives
Nicole M Breen director, 10 percent owner, officer: Secretary/Treasurer 4920 N. POST TRAIL, TUCSON AZ 85750
Elliot Kwestel director 5 AUERBACH LANE, LAWRENCE NY 11559
Lawrence G Dykers director 11924 N CENTAURUS PLACE, ORO VALLEY AZ 85737
Glynn A Burkhardt director, 10 percent owner, officer: Senior Vice President 3400 E. SPEEDWAY BLVD., SUITE 118-300, TUCSON AZ 85716
Roger Mccaslin director 11924 N. CENTAURUS PLACE, ORO VALLEY AZ 85737
Glenn E. Martin director, 10 percent owner, officer: President and Chairman of BOD 4920 N. POST TRAIL, TUCSON AZ 85750
Robert A Metz director, officer: Vice President 3400 E. SPEEDWAY BLVD., SUITE 118-300, TUCSON AZ 85716
Robert A Leitzman director, officer: CFO, CAO and V.P. 3400 E. SPEEDWAY BLVD., SUITE 118-300, TUCSON AZ 85716
Glynn A. Burkhardt director, 10 percent owner, officer: Senior V.P. 11924 N. CENTAURUS PLACE, ORO VALLEY AZ 85737
Donald J Steinberg director, officer: Former Officer and Director 3223 SUMAC ROAD, FALLBROOK CA 92028

Weed (BUDZ) Headlines

From GuruFocus

WEED Inc. Completes Proprietary Cannabis Genomics Pilot Study

By ACCESSWIRE AccessWire 04-12-2019